Last Updated: 19 Jun 2025
Source: Statifacts
The global industrial microbiology market size was evaluated at USD 14.11 billion in 2024 and is expected to grow around USD 26.15 billion by 2034, registering a CAGR of 6.36% from 2025 to 2034.
| Industry Worth | Details |
| Market Size in 2025 | USD 14.95 Billion |
| Market Size by 2034 | USD 26.15 Billion |
| Market Growth Rate from 2025 to 2034 | CAGR of 6.36% |
The industrial microbiology market talks about an applied section of microbiology that uses microorganisms for the manufacture of goods and services of financial worth. It makes use of microbes such as bacteria, fungi, and yeasts for producing antibiotics, food products, fuels, enzymes, drugs, amino acids, vaccines, and fine chemicals. This field of science can be applied in areas like wine and beer production, pharmaceuticals, diagnostic and testing services, agricultural products, and industrial enzymes.
This area of science can offer several possibilities to promote the use of biodegradable materials instead of plastics, thus lessening the carbon footprint on a global scale.
Some scientists are certain that bacteriophages, or phages, can treat diseases across the globe that cannot be treated any other way. Antimicrobial resistance (AMR) is one of the most dangerous diseases that can be treated through phage therapy. In the US, doctors can ask for emergency approval from the FDA to utilize this therapy when no other treatment options are left.
Talking about how artificial intelligence can bring change in the industrial microbiology sector, Raji said, “AI is nice for chatbots and LLMs, but some amazing, niche applications are paving the way for deep changes in certain industries, especially science-related industries. We are proud of being an example of it, while having developed in only one year our proprietary AI-based technology that manages to do what existing technologies couldn’t for two centuries.”
Artificial intelligence-based algorithms and tools are helping the industrial microbiology sector to grow on a large scale globally. Here’s how the industrial microbiology market has benefited from AI immeasurably:
The industrial microbiology market is experiencing significant growth worldwide, with concentrated growth in North America maintaining its position as the dominant region while Europe emerges as the fastest-growing market. The market of the APAC region is getting ahead at a steady pace.
North America
The market in North America has maintained an influential position owing to companies formulating new products using microbiology. The large number of biotechnology firms are leading research and development efforts in the region. With a lifestyle shift toward gut-healthy, plant-based products, and clean farming the demand for these engineered microbes is high in the food and beverage industries as well as in agriculture.
Ferment has introduced a new fund of $20 million for the studio to convert natural science into products helpful throughout diverse sectors such as energy, agriculture, materials, and health.
Europe
The European market is leading the way forward, given that the companies in the region are reinventing microbiology testing. Technological advances, and government support in the form of European Technology Platforms was one of the initiatives launched by the European Commission in 2003.
Paris-based company Spore. Bio announced that it has raised $23M to transform microbiology testing by drastically reducing the processing time.
Asia Pacific
The industrial microbiology market in the Asia Pacific region is growing at a steady pace as a consequence of the big companies supporting the budding firms in research and development. The market in Asia Pacific is expanding rapidly due to rising investments in biotechnology, and a growing focus on microbial research.
NSG BioLabs has formed a collaboration with Merck Singapore to make resources and expertise available to biotechnology start-ups with an aim to reinforce the research and development competencies of NSG BioLabs' occupants.
The industrial microbiology market is highly competitive, with leading pharmaceutical companies such as Johnson & Johnson, Pfizer, Merck KGaA, Roche Diagnostics, Danaher Corporation, GSK, AbbVie, Amgen, AstraZeneca, Qiagen NV, and Sartorius AG holding the highest market share. Emerging biotech firms also play a crucial role by fostering a dynamic and evolving competitive landscape.
The market is dominated by several pharmaceutical companies renowned for their significant contributions to research in the field of industrial microbiology. Based on fresh data, the top three leading companies are:
The yearly revenue of Johnson & Johnson was accounted to be $88,821,000 in 2024.
The gross profit of Pfizer leaped from $34,599,000 in 2023 to $45,776,000 in 2024.
The annual revenue of Merck KGaA was positioned at $21,156,000 in 2024.
Published by Ajit Bansod
